InsiderPulse
← 10-K / 10-Q
10-KRMTG

Regenerative Medical Technology Group Inc.

Filed 2026-05-14Period ending 2025-12-31
EDGAR ↗All periods →

Income Statement

Line Item2025-12-31Y/Y
Revenue$5.1M+24.2%
Cost of Revenue$2.3M+78.3%
Gross Profit$2.8M-0.4%
SG&A Expense$1.1M+40.3%
Operating Income-$867K-1168.2%
Income Tax-$1.6M-41.1%
Net Income-$7.8M-40.4%
EPS (Basic)-$0.62-40.9%
EPS (Diluted)-$0.62-40.9%

Balance Sheet

Line Item2025-12-31Y/Y
Cash & Equivalents$957K-17.9%
Accounts Receivable$44K+93.8%
Inventory$159K+1474.7%
Current Assets$1.2M-2.0%
Total Assets$4.5M+17.5%
Current Liabilities$36.8M+27.1%
Long-term Debt$4
Total Liabilities$39.2M+25.8%
Stockholders' Equity-$34.7M-27.0%

Cash Flow

Line Item2025-12-31Y/Y
Operating Cash Flow-$707K-183.1%
Capital Expenditures$603K+179.7%
Investing Cash Flow-$603K-179.7%
Financing Cash Flow$1.1M
Free Cash Flow-$1.3M-306.1%